BioCentury
ARTICLE | Finance

Off the agenda

Diagnostics company Agendia pulls Euronext IPO, citing market volatility

June 27, 2011 7:00 AM UTC

Molecular diagnostics play Agendia B.V. was slated for an IPO last week, but instead it pulled the offering, citing the volatile stock market.

Earlier this month, the company said it expected to start trading on June 21 on NYSE Euronext in Amsterdam. It had hoped to raise up to €75 million ($109.6 million) through the sale of up to 4.6 million shares at €16.35-€19.15 in the IPO...